Agilent Technologies Inc. has launched new 21 CFR Part 11 compliant software for its xCELLigence Real-Time Cell Analysis (RTCA) eSight system
Biocon Biologics is moving fast after securing a major settlement with Amgen that clears the way for its Denosumab biosimilars to enter Europe and global markets. Starting December 2, 2025, the company can commercialize both Vevzuo and Evfraxy...
RPG Life Sciences is stepping into India’s growing GLP-1 market — targeting obesity and diabetes — and laying the groundwork for a bold expansion that could reshape its future. The company has outlined an ambition to reach ?2,500 crore turnover...
The Union health ministry's Drugs Consultative Committee (DCC) has advised the government to modify the Drugs and Cosmetic Rules (D&C Rules) to grant licenses to pharmaceutical marketers under specific conditions aimed at guaranteeing the quality
Cipla Limited has unveiled its first Breathefree Lung Wellness Centre in Lajpat Nagar, New Delhi—marking the debut of India’s first integrated lung diagnostics and wellness facility
Zydus Lifesciences has obtained a provisional license from the U.S. Food and Drug Administration on Empagliflozin and Linagliptin pills. This is a milestone in the U.S. expanding portfolio of the company. It reports about the generic Glyxambi...
Glenmark Pharmaceuticals has launched the world’s first nebulized triple therapy for COPD, marking a major step forward in respiratory care. The new products — Nebzmart GFB Smartules and Glenmark Airz FB Smartules — blend Glycopyrronium...
Apollo Hospitals opened its latest healthcare facility in Swargate, Pune, on Monday, marking its third hospital in Maharashtra and further expanding its presence in western India
Alkem Laboratories Ltd has introduced DSS, the original De Simone formulation probiotic mixture in India, aimed at restoring gut microbiota equilibrium and addressing several gut-related health issues.
Eli Lilly has become the first drugmaker to reach a $1?trillion market valuation, driven by soaring demand for its weight?loss and diabetes drugs. This ascension is indicative of how the weight-loss drug market, which was initially a niche, has...
.jpg)
.jpg)
, CDSCO.jpg)